Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2017 | Tracking an immunoscore throughout treatment

Jerome Galon • 5 Nov 2017
NCRI 2017
General

An immunoscore is an evaluative test of a cancer patient’s adaptive immune activity towards their tumor, and can predict survival, recurrence and treatment response. Here, Jerome Galon, PhD, of Cordeliers Research Center, Paris, France, describes how the immunoscore could be used on tumor biopsies before, during and after a course of treatment to evaluate the efficacy of the therapy and monitor the patient’s wellbeing. This video was recorded at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK.

More from Jerome Galon

1:07
Heating up a tumor: modulating the immunoscore
Jerome Galon • 5 Nov 2017
0:36
Presenting the immunoscore
Jerome Galon • 5 Nov 2017
1:59
The immunoscore: a new way of stratifying cancer
Jerome Galon • 5 Nov 2017
1:12
The immunoscore: the most powerful predictor of cancer recurrence and survival
Jerome Galon • 5 Nov 2017

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals